Gerhardt, Louisa M. S.
Kordsmeyer, Maren
Sehner, Susanne
Güder, Gülmisal
Störk, Stefan
Edelmann, Frank
Wachter, Rolf
Pankuweit, Sabine
Prettin, Christiane
Ertl, Georg
Wanner, Christoph
Angermann, Christiane E. http://orcid.org/0000-0001-7491-7637
Funding for this research was provided by:
Federal Ministry of Education and Research (01GL0304)
Competence Network Heart Failure Germany (01GI0205, 01GI1202A)
Heart Failure Society of America (01EO1004)
Julius-Maximilians-Universität Würzburg
Article History
Received: 25 November 2021
Accepted: 25 April 2022
First Online: 1 June 2022
Change Date: 12 September 2022
Change Type: Update
Change Details: The last part of the Open Access funding information has been corrected to read: “Open Access funding enabled and organized by Projekt DEAL.”
Declarations
:
: CEA reports grant support, personal fees and/or non-financial support from Abbott, AstraZeneca, Boehringer Ingelheim, Medtronic, Novartis, ResMed, Thermo Fisher and Vifor, all outside of the submitted work. She further acknowledges non-financial support from the University Hospital Würzburg, non-financial support from Comprehensive Heart Failure Center Würzburg and grant support from German Ministry for Education and Research (BMBF). GG received grant support from the Federal Ministry of Education and Research, the German Heart Foundation, the German Society for Cardiology and has been a consultant for AstraZeneca, Abiomed, Bayer, Boehringer Ingelheim, Novartis, Orion GmbH, Pfizer, and Vifor. StS reports grant support and/or personal fees from AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Pfizer, Servier and Sanofi, all outside the submitted work. He further reports grant support from German Ministry of Education and Research, European Union, and University Hospital Würzburg. FE has been a consultant or speaker for AstraZeneca, Bayer, Merck, Boehringer Ingelheim, CVRx, Pfizer, Medtronic, Biotronic, ResMed, Berlin Chemie, Actelion, Thermo Fisher, Novartis, PharmaCosmos and Vifor, all outside the submitted work. He further reports grant support from the Federal Ministry of Education and Research and the German Centre for Cardiovascular Research (DZHK). RW reports personal fees from Bayer, Berlin Chemie, Bristol-Myers-Squibb, Boehringer Ingelheim, Boston Scientific, CVRx, Gilead, Johnson & Johnson, Medtronic, Novartis, Pfizer, Relypsa, Sanofi and Servier, all outside the submitted work. He has also received research grants from Boehringer Ingelheim, European Union, German Research Foundation (DFG) and Federal Ministry for Education and Research (BMBF). GE reports personal fees from AstraZeneca, Abbott, Boehringer Ingelheim, Novartis and Vifor, all outside the submitted work. He further acknowledges non-financial support from the University Hospital Würzburg, non-financial support from Comprehensive Heart Failure Center Würzburg and grant support from German Ministry for Education and Research (BMBF). CW reports personal fees from Akebia, AstraZeneca, Bayer, Boehringer Ingelheim, Chiesi, FMC, Gilead, GSK, Lilly, MSD, Sanofi-Genzyme, Takeda and Tricida, all outside the submitted work. He further reports non-financial support from Comprehensive Heart Failure Center Würzburg and grant support from Federal Ministry for Education and Research (BMBF). All other authors have no conflicts of interest to report.